Verified · Documented · Trusted

Age & Research Use Verification

Please confirm both statements to continue.

Exit Site

By entering, you agree to our Terms of Service and Privacy Policy. This site sells laboratory reagents strictly for in-vitro research use only, not for human or veterinary consumption.

Skip to content
Free UPS Ground $150+ · Free 2nd Day Air $200+
All Articles Shop Products

// Research Library

BPC-157 + TB-500 Blend: Research Overview of a Two-Peptide Tissue Research Vial

·Genetic Peptides USA

BPC-157 and TB-500 are two of the most frequently compared short peptides in tissue and cell research, and pre-mixed vials exist so both can be supplied together. This overview covers the BPC-157 + TB-500 blend: what each component is, why labs study them side by side, the trade-offs of a fixed-ratio vial, and how to read a two-component COA. For BPC-157 on its own, see the BPC-157 research guide.

The Two Components

BPC-157

BPC-157 is a synthetic 15-amino-acid peptide (GEPPPGKPADDAGLV) with a molecular weight of about 1,419 Da. Its sequence is derived from a larger protein described in gastric juice, and it is studied in preclinical cell-migration, angiogenic-signaling and growth-factor-pathway models.

TB-500

TB-500 is the research name for synthetic Thymosin Beta-4 (43 amino acids, MW ~4963 Da, CAS 77591-33-4). It is used in actin polymerization, cell-migration and endothelial tube-formation assays.

Why Researchers Study the Pairing

The two peptides are thought to act through different mechanisms: TB-500 through actin binding, BPC-157 through signaling pathways reported in preclinical studies. That makes them a natural pair for designs that compare each alone with the combination. A blend supplies both in a fixed 1:1 ratio (5mg BPC-157 and 5mg TB-500 per vial). The trade-off is that the ratio cannot be varied between experimental arms. See BPC-157 vs TB-500: mechanisms and research pairing and single-compound vials vs pre-mixed blends.

Common In-Vitro Designs

  • Scratch (wound-closure) assays comparing each peptide alone with the combination.
  • Endothelial tube-formation assays.
  • Gene and protein expression studies of cytoskeletal and growth-factor markers.
  • Analytical method development for resolving two short peptides in one sample.

Findings in cell or animal models do not establish any effect in people.

What a Two-Component COA Should Report

A blend certificate is most useful when it reports each peptide separately: two HPLC peaks with individual purity values and mass spectrometry confirming both identities. For the TB-500 component, the observed mass should be consistent with Thymosin Beta-4 (approximately 4963 Da; CAS 77591-33-4). A single combined purity number tells you less. Our current blend lot certificate reports separate purity values for BPC-157 and TB-500 and is published on the product page and in the COA library. See how to read a COA and batch-specific vs representative COAs.

Specifications at a Glance

  • Components: BPC-157 (15 aa) + TB-500 (synthetic Thymosin Beta-4, 43 aa, MW ~4963 Da, CAS 77591-33-4)
  • Size: 5mg / 5mg in one vial
  • Form: co-lyophilized powder
  • Verification: HPLC purity and MS identity per component, third-party tested

Where to Go Next

View the BPC-157 + TB-500 Blend 5/5mg, the single-compound BPC-157 and TB-500 pages, or browse the Tissue Research and Peptide Blends collections. Related: Tesamorelin + Ipamorelin blend overview, CJC-1295 + Ipamorelin blend overview, and the pillar Researcher's Guide to Peptides in 2026.

Frequently Asked Questions

What is in a BPC-157 + TB-500 blend?

One lyophilized vial containing 5mg of BPC-157, a synthetic 15-amino-acid peptide, and 5mg of TB-500 (synthetic Thymosin Beta-4, 43 amino acids, MW ~4963 Da, CAS 77591-33-4).

Why do researchers study BPC-157 and TB-500 together?

They are thought to act through different mechanisms, actin binding for TB-500 and signaling pathways for BPC-157, so preclinical designs compare each alone and in combination.

Is a blend better than separate vials?

It depends on the study. A blend gives a fixed 1:1 ratio from one vial, while separate vials let a lab vary the amount of each peptide between experimental arms.

What should a blend COA show?

Separate HPLC purity values for each peptide and mass spectrometry confirming both identities, tied to a lot number and test date that match the vial.

Is this blend for human use?

No. It is sold for laboratory research use only, not for human or veterinary use, and is not intended to diagnose, treat, cure, or prevent any disease.

All products referenced in this article are sold strictly for laboratory research use only. They are not for human or veterinary use, are not drugs, foods, or cosmetics, and are not intended to diagnose, treat, cure, or prevent any disease. A Certificate of Analysis is an analytical record for a tested sample; it is research verification only and is not a statement of safety or suitability for any use outside a qualified laboratory.

Research Guide

// Third-Party Verified

Browse the Research Catalog

Independently third-party tested compounds, 99%+ purity on tested lots. Certificates of analysis are published on the product pages that carry them.

View All Products

More From the Research Library

11 NOV 2026
TB-500 Research Peptide Overview: Synthetic Thymosin Beta-4 and COA Checks
11 NOV 2026
TB-500 and Thymosin Beta-4: CAS Number and Mass on a COA
11 NOV 2026
CJC-1295 + Ipamorelin Blend: Research Overview of a GHRH Analog and GHS Pairing

All products are for in-vitro laboratory research use only. Not for human or animal consumption. This article is provided for informational purposes to a research audience and is not medical advice. Questions? Support@GeneticPeptidesUSA.com

🧬 Ask AI
🧬
GPUSA Research Assistant
Online
Hi! I'm the Genetic Peptides USA research assistant. I can help with questions about our products, pricing, shipping and orders. What can I help you with?
For research purposes only · Not medical advice